Authors
Loading...
Single-center analysis reveals CMA identifies 3.2% more chromosomal abnormalities, suggesting its routine use in high-risk pregnancies.
Bakır et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: